Fulvestrant (Fazlodeks)v dozirovke 500 mg uvelichivaet medianuobshchey vyzhivaemosti na 4,1 mes po sravneniyus dozirovkoy 250 mg
- 作者: - -
- 期: 卷 14, 编号 4 (2012)
- 页面: 6-
- 栏目: Articles
- ##submission.dateSubmitted##: 09.04.2020
- ##submission.datePublished##: 15.12.2012
- URL: https://modernonco.orscience.ru/1815-1434/article/view/29515
- ID: 29515
如何引用文章

